China Life Asset Management Co., Ltd. (hereinafter referred to as "China Life Asset Management") has successfully initiated and established the "China Life - Hainashenchuang Equity Investment Plan" with a scale of approximately 5 billion yuan, which will invest in Shanghai Xinhechuang No. 1 Private Investment Fund (hereinafter referred to as "Xinhechuang No. 1 Fund"). The successful launch of this project is a powerful measure by China Life Asset Management to implement the decisions and deployments of the Central Committee, marking the company's first breakthrough in proactively supporting mergers, acquisitions, and integration in key industries, and exploring an innovative path for insurance funds to leverage their patient capital advantages, support the development of new productive forces, and enhance regional development vitality.
The Fourth Plenary Session of the 20th Central Committee made important deployments for the "15th Five-Year Plan" period to "accelerate high-level scientific and technological self-reliance and self-improvement, and lead the development of new productive forces." Integrated circuits, as the foundation of modern industry, hold a strategically core position in achieving high-level scientific and technological self-reliance. As a key component of Shanghai's state-owned capital M&A fund matrix, the Xinhechuang No. 1 Fund focuses on EDA software, a critical "bottleneck" segment within the integrated circuit industry, aligning with trends in industrial consolidation and capital market direction to achieve deep integration of state-owned system resources, industry chain partner resources, and social capital, thereby laying a solid foundation for industrial synergy and future integration in the EDA field. This project is the first investment research conversion collaboration following the establishment of the "China Life Asset Management - Shanghai Guotou Joint Innovation Laboratory," and also represents China Life Asset Management's initial exploration, guided by its "dual-line allocation" methodology, of research-driven investment and deployment in M&A funds; by investing in an industrial M&A fund focused on a key area with regional comparative advantages, it adds fintech support to the construction of Shanghai's international science and technology innovation center and provides patient capital support for the development of China's key industrial sectors.
In recent years, China Life Asset Management has resolutely implemented the decisions and deployments of the Central Committee, deeply grasped the political and people-oriented nature of financial work, anchored its goals on building a strong financial nation, and solidly advanced the "Five Key Areas of Finance," accelerating high-quality development. As of the end of the third quarter of 2025, China Life Asset Management's consolidated assets under management approached nearly 7 trillion yuan, with over 4 trillion yuan serving the real economy; through in-depth service to the forefront and strategic sectors of real economic development, it has successfully launched a number of influential investment projects, represented by the "China Life - Hufa No. 1 Equity Investment Plan."
Moving forward, China Life Asset Management will continue to deepen reforms and innovation across its "four-in-one" framework, actively leverage the long-term investment and patient capital advantages of insurance funds, further increase support for strategic emerging industries, future industry layouts, and upgrades in traditional industries, better serve the development of new productive forces, contribute to the implementation of the "15th Five-Year Plan" and the building of a strong nation in science and technology and finance, and dedicate its strength to advancing Chinese modernization.
Comments